The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of complete pathologic response after neoadjuvant immunotherapy for MSI-H gastrointestinal cancers.
 
Kruti Bhagirath Vora
No Relationships to Disclose
 
Ben Ouyang
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics; Pfizer
Patents, Royalties, Other Intellectual Property - Tissium
 
Leon Pappas
No Relationships to Disclose
 
Kerry Lynn Reynolds
Employment - Project Data Sphere; Teladoc
Stock and Other Ownership Interests - Biogen (I)
Other Relationship - Project Data Sphere
 
Matthew Strickland
No Relationships to Disclose
 
Jill N. Allen
No Relationships to Disclose
 
Colin D. Weekes
Honoraria - Bayer; Celgene; Lilly
Consulting or Advisory Role - Celgene; Ipsen; Merrimack
Research Funding - Actuate Therapeutics; AstraZeneca; Celgene; Dicephera Pharmaceuticals, Inc.; Genentech/Roche; Novartis
 
Ryan Bruce Corcoran
Leadership - Alterome Therapeutics
Stock and Other Ownership Interests - Alterome Therapeutics; Avidity Biosciences; C4 Therapeutics; Cogent Biosciences; Erasca, Inc; Interline Therapeutics; Kinnate Biopharma; Nested Therapeutics; nRichDx; Remix Therapeutics; Revolution Medicines; Theonys
Consulting or Advisory Role - Abbvie; Array BioPharma; Asana Biosciences; C4 Therapeutics; Elicio Therapeutics; FOGPharma; Ipsen; Kinnate Biopharma; N-of-One; Natera; nRichDx; Remix Therapeutics; Revolution Medicines; Taiho Pharmaceutical
Research Funding - Lilly; Novartis; Pfizer
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I)
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; Bioimpact Capital; Cullinan Oncology; Exact Sciences; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Innocrin Pharma; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics
 
Joseph Wang Franses
Stock and Other Ownership Interests - Biogen; Merck
Consulting or Advisory Role - Foundation Medicine
Research Funding - Genentech/Roche (Inst)
 
Sakti Chakrabarti
Honoraria - Natera
Speakers' Bureau - Natera
 
Samuel J Klempner
Stock and Other Ownership Interests - Nuvalent, Inc.; TP Therapeutics
Honoraria - Natera
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Exact Sciences; Lilly; Merck; Mersana; Novartis; Pieris Pharmaceuticals; Sanofi/Aventis
Research Funding - BeiGene (Inst); Leap Therapeutics (Inst); Silverback Therapeutics (Inst)
Other Relationship - NCCN
 
Aparna Raj Parikh
Consulting or Advisory Role - Abbvie; Bayer; Biofidelity; Checkmate Pharmaceuticals; CVS; Delcath Systems; Delcath Systems; Foundation Medicine; Genconn Biotech; Genconn Biotech; Guardant Health; Illumina; Inivata; Lilly; Natera; Pfizer; Roche/Genentech; SAGA Diagnostics; Scarce; Seagen; Taiho Oncology; UpToDate; Value Analytics Labs; xCures; xCures
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
Other Relationship - C2i genomics; Parithera; Xact Robotics